Ceres Pharma has enhanced its offering in women’s health by acquiring Kela Pharma from Belgium-based Kela for an undisclosed sum.
Describing the deal as an “important step” towards its goal of building a leading position in Europe’s consumer health market, Ceres said Kela Pharma would in particular
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?